Subgroup Analyses in Randomized Clinical Trials: Statistical and Regulatory Issues
Autor: | Jean-Marie Grouin, Maylis Coste, John Lewis |
---|---|
Rok vydání: | 2005 |
Předmět: |
Pharmacology
Statistics and Probability Models Statistical Multivariate analysis business.industry MEDLINE Data interpretation Subgroup analysis law.invention Clinical trial Randomized controlled trial Sample size determination law Data Interpretation Statistical Sample Size Multivariate Analysis Econometrics Medicine Pharmacology (medical) business Randomized Controlled Trials as Topic Clinical psychology |
Zdroj: | Journal of Biopharmaceutical Statistics. 15:869-882 |
ISSN: | 1520-5711 1054-3406 |
Popis: | Recently, two CPMP Points to Consider, one on adjustment for baseline covariates and the other on multiplicity issues in clinical trials, have included recommendations on the use of subgroup analysis for regulatory purposes. However, despite their regular use and regulatory attention, the validity and nature of subgroup analyses are still frequently questioned. This article provides guidance on when subgroup analyses can be done, when they should be done, and their interpretation. The validity of common regulatory claims based on subgroup analyses is then discussed. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |